C32-O-imidazol-2-yl-methyl ether derivatives of the immunosuppressant ascomycin with improved therapeutic potential
- 1 August 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (16) , 2253-2258
- https://doi.org/10.1016/s0960-894x(98)00397-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- C32-amino derivatives of the immunosuppressant ascomycinBioorganic & Medicinal Chemistry Letters, 1997
- Preparation and in vitro activities of naphthyl and indolyl ether derivatives of the FK-506 related immunosuppressive macrolide ascomycinBioorganic & Medicinal Chemistry Letters, 1996
- Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complexNature, 1995
- Preparation and in vitro activity of aryl ether derivatives of the FK-506 related immunosuppressive macrolides ascomycin and L-683,742Bioorganic & Medicinal Chemistry Letters, 1995
- Alkyl ether analogs of the FK-506 related, immunosuppressive macrolide L-683,590 (ascomycin)Bioorganic & Medicinal Chemistry Letters, 1994
- The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.The Journal of Experimental Medicine, 1992
- FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurinNature, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Eine neue Synthese von Imidazol‐DerivatenBerichte der deutschen chemischen Gesellschaft (A and B Series), 1935